Real World Study on the Reasons for eScalation or de-Escalation of Inhaled ThEraPies in COPD Patients: the STEPINCOPD Multicenter Observational Study

Real World Study on the Reasons for eScalation or de-Escalation of Inhaled ThEraPies in COPD Patients: the STEPINCOPD Multicenter Observational Study

Background There is limited data on the reasons for escalation or de-escalation of COPD inhaled therapies in routine clinical practice, especially after the follow-up pharmacological treatment guidance on the 2019 GOLD report and the 2020 ERS guideline on ICS withdrawal.Methods The STEPINCOPD study...

Full description

Saved in:
Bibliographic Details
Main Authors: Argyris Tzouvelekis, Christos Kyriakopoulos, Irini Gerogianni, Aggeliki Rapti, Vasileios Michailidis, Andreas Dimoulis, Despina Papakosta, Paschalis Steiropoulos, Panagiota Styliara, Konstantinos Kostikas, Athena Gogali
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:COPD
Subjects:
COPD
treatment change
escalation
inhalers
LABA/LAMA
Online Access:https://www.tandfonline.com/doi/10.1080/15412555.2024.2427755
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/15412555.2024.2427755

Similar Items